PAX5 and acute lymphoblastic leukemia: To date, the development of BCP‐ALL in the vast majority of cases with PAX5 germline mutations has been attributed to second‐hit somatic variants affecting the wild‐type allele (structural variants, loss of heterozygosity (LOH) on chromosome 9p, and PAX5 point mutations) [6, 7, 8].